CellCarta
Montr├⌐al · Founded 2002
About CellCarta
CellCarta's Mission is centered on collaborating and partnering with pharmaceutical and biotech companies through proteomics and immune monitoring enabling the acceleration of precision medicine in drug development. With a vision and deep understanding of the needs for complex immune monitoring in novel drug development, Caprion integrated ImmuneCarta (formerly known as National Immune Monitoring), with its established and proven proteomics service, ProteoCarta. Together, Caprion now offers a fully integrated and unique service offering to its partners.
Company Facts
- Founded: 2002
- Legal name: CAPRION Biosciences Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $100K – $500K
- Website: caprion.com
- Phone: 5143603601
Social Profiles
Canonical: https://fsome.com/organization/cellcarta-8441856 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.